ONCOtracker, Inc is a West Hollywood-based oncology company pursuing intellectual property for innovative treatments leading to dramatically improved outcomes. It is a leading incubator for cancer treatment innovations with a focus on the diagnosis and treatment of multiple myeloma, other B-cell malignancies and related disorders. It has exclusive rights to the serum B-Cell maturation antigen (sBCMA) blood test, which is being developed to monitor changes in tumor burden and predict therapeutic outcomes of multiple myeloma patients. sBCMA is being investigated for clinical application in chronic lymphocytic leukemia, B-cell lymphoma and select solid tumor malignancies. ONCOtracker has intellectual property related to novel treatment approaches for multiple myeloma, which are being pursued in ongoing clinical trials.
| Website | http://www.oncotracker.com |
| Revenue | $5.5 million |
| Employees | View employees |
| Founded | 2014 |
| Address | 9201 Sunset Blvd Ste 300, West Hollywood, California 90069, US |
| Phone | +1 424-204-0734 |
| Fax | (310) 623-1120 |
| Industry | Medical Testing & Clinical Laboratories, Pharmaceutical, Laboratory Services (Healthcare), Healthcare, Health Care, Monitoring Equipment |
| Competitors | Tempus Labs, Inc., Guardant Health, Foundation Medicine, NeoGenomics Laboratories, bluebird bio, Freenome, Strata Oncology, Epic Sciences, carisls +42 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies, SIC Code 8071 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies |
Looking for a particular OncoTracker Inc employee's phone or email?
OncoTracker Inc Questions
The OncoTracker Inc annual revenue was $5.5 million in 2026.
OncoTracker Inc is based in West Hollywood, California.
The NAICS codes for OncoTracker Inc are [6215, 621, 62, 62151].
The SIC codes for OncoTracker Inc are [80, 807, 8071].
